Catalyst Wire Dossier Catalyst Wire Dossier

GSK2585823

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GSK2585823, covering 2017-07-26 to 2018-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects [Phase 3]

See pricing